Pretreatment synthetic MRI features for triple-negative breast cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pretreatment synthetic MRI features for triple-negative breast cancer
Authors
Keywords
-
Journal
CLINICAL RADIOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-31
DOI
10.1016/j.crad.2023.10.015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrated Analysis Reveals the Molecular Features of Fibrosis in Triple-Negative Breast Cancer
- (2022) Jia-Han Ding et al. Molecular Therapy-Oncolytics
- Is simultaneous multi-slice readout-segmented echo-planar imaging valuable for predicting molecular subtypes of breast cancer?
- (2022) Xue Li et al. EUROPEAN JOURNAL OF RADIOLOGY
- Synthetic MRI with quantitative mappings for identifying receptor status, proliferation rate, and molecular subtypes of breast cancer
- (2022) Weibo Gao et al. EUROPEAN JOURNAL OF RADIOLOGY
- Utility of synthetic MRI in predicting pathological complete response of various breast cancer subtypes prior to neoadjuvant chemotherapy
- (2022) M. Matsuda et al. CLINICAL RADIOLOGY
- Antithrombotic Therapy and Hematoma Risk during Image-guided Core-Needle Breast Biopsy
- (2022) Vilert A. Loving et al. RADIOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Histogram analysis of quantitative parameters from synthetic MRI: Correlations with prognostic factors and molecular subtypes in invasive ductal breast cancer
- (2021) Qin Li et al. EUROPEAN JOURNAL OF RADIOLOGY
- Triple-negative breast cancer on contrast-enhanced MRI and synthetic MRI: A comparison with non-triple-negative breast carcinoma
- (2021) Megumi Matsuda et al. EUROPEAN JOURNAL OF RADIOLOGY
- Utility of synthetic MRI in predicting the Ki-67 status of oestrogen receptor-positive breast cancer: a feasibility study
- (2020) M. Matsuda et al. CLINICAL RADIOLOGY
- Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI
- (2020) Yadong Cui et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Enhanced Masses on Contrast‐Enhanced Breast: Differentiation Using a Combination of Dynamic Contrast‐Enhanced MRI and Quantitative Evaluation with Synthetic MRI
- (2020) Megumi Matsuda et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI
- (2020) Tiebao Meng et al. CANCER IMAGING
- Improved discrimination of molecular subtypes in invasive breast cancer: Comparison of multiple quantitative parameters from breast MRI
- (2020) Siyao Du et al. MAGNETIC RESONANCE IMAGING
- Joint Prediction of Breast Cancer Histological Grade and Ki-67 Expression Level Based on DCE-MRI and DWI Radiomics
- (2019) Ming Fan et al. IEEE Journal of Biomedical and Health Informatics
- Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions
- (2018) Keum Won Kim et al. ACADEMIC RADIOLOGY
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results
- (2018) Julian A. Luetkens et al. RADIOLOGY
- An explorative analysis of the prognostic value of lactate dehydrogenase for survival and the chemotherapeutic response in patients with advanced triple-negative breast cancer
- (2018) Zhenya Jia et al. Oncotarget
- Morphological and Semiquantitative Kinetic Analysis on Dynamic Contrast Enhanced MRI in Triple Negative Breast Cancer Patients
- (2018) Silvia Gigli et al. ACADEMIC RADIOLOGY
- Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancer
- (2016) Bo Chen et al. Journal of Cancer
- Taxane benefit in breast cancer—a role for grade and chromosomal stability
- (2013) Roger P. A'Hern et al. Nature Reviews Clinical Oncology
- Imaging of triple-negative breast cancer
- (2012) B. E. Dogan et al. ANNALS OF ONCOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
- (2009) B. K. Linderholm et al. ANNALS OF ONCOLOGY
- Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy
- (2009) Eugenio Maiorano et al. BREAST CANCER RESEARCH AND TREATMENT
- Breast cancer seeding associated with core needle biopsies: A systematic review
- (2009) Fabienne Liebens et al. MATURITAS
- Triple-Negative Breast Cancer: Correlation between MR Imaging and Pathologic Findings
- (2009) Takayoshi Uematsu et al. RADIOLOGY
- Breast magnetic resonance imaging for preoperative locoregional staging
- (2008) Alan B. Hollingsworth et al. AMERICAN JOURNAL OF SURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started